Your browser doesn't support javascript.
loading
Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report.
Yang, Chao; Gao, Bixia; Zhao, Xinju; Su, Zaiming; Sun, Xiaoyu; Wang, Huai-Yu; Zhang, Ping; Wang, Rong; Liu, Jian; Tang, Wen; Zhang, Dongliang; Chu, Hong; Wang, Jinwei; Wang, Fang; Wang, Song; Zuo, Li; Wang, Yue; Yu, Feng; Wang, Haibo; Zhang, Luxia; Zhang, Hong; Yang, Li; Chen, Jianghua; Zhao, Ming-Hui.
Afiliação
  • Yang C; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Gao B; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Zhao X; Department of Nephrology, Peking University People's Hospital, Beijing, China.
  • Su Z; National Institute of Health Data Science at Peking University, Beijing, China.
  • Sun X; National Institute of Health Data Science at Peking University, Beijing, China.
  • Wang HY; National Institute of Health Data Science at Peking University, Beijing, China.
  • Zhang P; Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Wang R; Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China.
  • Liu J; Division of Nephrology, the First Hospital of Xinjiang University of Medicine, Uramuqi, Xinjiang, China.
  • Tang W; Department of Nephrology, Peking University Third Hospital, Beijing, China.
  • Zhang D; Department of Nephrology, Peking University International Hospital, Beijing, China.
  • Chu H; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Wang J; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Wang F; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Wang S; Department of Nephrology, Peking University Third Hospital, Beijing, China.
  • Zuo L; Department of Nephrology, Peking University People's Hospital, Beijing, China.
  • Wang Y; Department of Nephrology, Peking University Third Hospital, Beijing, China.
  • Yu F; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China; Department of Nephrology, Peking Uni
  • Wang H; National Institute of Health Data Science at Peking University, Beijing, China.
  • Zhang L; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; National Institute of Health Data Science at Peking University, Beijing, China; Advanced Institute of Information Technology, Peking University, Hangzhou, Zhejiang, Ch
  • Zhang H; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Yang L; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Chen J; Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Zhao MH; Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China; Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China; Peking-Tsinghua Center for Life Scie
Kidney Int ; 98(6): 1419-1423, 2020 12.
Article em En | MEDLINE | ID: mdl-33276868
ABSTRACT
Chronic kidney disease (CKD) has been recognized as a public health problem globally. The spectrum of CKD in China has been evolving toward that of developed countries, which will have enormous impacts on the health care system. However, there has been no well-established national surveillance system for kidney diseases. Furthermore, China still faces several challenges of kidney care, including limited capacity and efficiency, suboptimal awareness, and huge heterogeneity in diagnosis and treatment. The China Kidney Disease Network has published 2 reports regarding the burden of CKD and end-stage kidney disease in China and intends to become a comprehensive surveillance system for kidney diseases based on multisource data. With the expansion of research group and data sources, the content of the China Kidney Disease Network 2016 Annual Data Report was further enriched. Section I addresses the epidemiologic characteristics of patients with CKD based on a national inpatient database, Hospital Quality Monitoring System, covering more than 52% of China's tertiary hospitals in China in 2016. Section II focuses on the burden of patients receiving dialysis, mainly based on the nationwide claims database, China Health Insurance Research Association database, which collects data from approximately 2% of the insured population from the municipalities/provincial capital cities and approximately 5% from the prefecture-level cities. An independent chapter regarding dialysis in 3 provincial dialysis quality control centers has been added. The China Kidney Disease Network 2016 Annual Data Report symbolizes a successful team effort in the era of big data, with support from the specialists and partners of the collaborative network, which is of substantial value for understanding the burden of kidney diseases in China and developing prevention and control strategies.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Falência Renal Crônica Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Kidney Int Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Falência Renal Crônica Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Kidney Int Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China